Incline Therapeutics Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$187M
Incline Therapeutics General Information
Description
Developer of IONSYS, a potential analgesic for adult inpatients requiring opioid pain treatment after surgery. The company develops a compact, disposable, needleless Patient-Controlled Analgesia system for the short-term management of postoperative pain.
Contact Information
Website
www.inclinethera.comCorporate Office
- 900 Saginaw Drive
- Suite 200
- Oakland, CA 94603
- United States
Corporate Office
- 900 Saginaw Drive
- Suite 200
- Oakland, CA 94603
- United States
Incline Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 07-Jan-2013 | $187M | Completed | Product Development | ||
| 2. Early Stage VC (Series A) | 13-Sep-2011 | Completed | Product Development | |||
| 1. Merger/Acquisition | 22-Jun-2010 | Cancelled | Product Development |
Incline Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Incline Therapeutics Patents
Incline Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2949709-A1 | Switch validation circuit and method | Inactive | 04-Jun-2014 | ||
| EP-3151905-A1 | Switch validation circuit and method | Inactive | 04-Jun-2014 | ||
| EP-3151905-A4 | Switch validation circuit and method | Inactive | 04-Jun-2014 | ||
| WO-2015187834-A1 | Switch validation circuit and method | Inactive | 04-Jun-2014 | ||
| ES-2635242-T3 | Current control for drug delivery by electrotransport | Active | 11-Jun-2012 | A61N1/325 |
Incline Therapeutics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| Adams Street Partners | PE/Buyout | Minority | ||
| Cadence Pharmaceuticals | Corporation | Minority | ||
| Emergent Medical Partners | Venture Capital | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority |
Incline Therapeutics FAQs
-
When was Incline Therapeutics founded?
Incline Therapeutics was founded in 2009.
-
Where is Incline Therapeutics headquartered?
Incline Therapeutics is headquartered in Oakland, CA.
-
What industry is Incline Therapeutics in?
Incline Therapeutics’s primary industry is Drug Discovery.
-
Is Incline Therapeutics a private or public company?
Incline Therapeutics is a Private company.
-
What is the current valuation of Incline Therapeutics?
The current valuation of Incline Therapeutics is .
-
What is Incline Therapeutics’s current revenue?
The current revenue for Incline Therapeutics is .
-
How much funding has Incline Therapeutics raised over time?
Incline Therapeutics has raised $43M.
-
Who are Incline Therapeutics’s investors?
5AM Ventures, Adams Street Partners, Cadence Pharmaceuticals, Emergent Medical Partners, and Frazier Healthcare Partners are 5 of 7 investors who have invested in Incline Therapeutics.
-
When was Incline Therapeutics acquired?
Incline Therapeutics was acquired on 07-Jan-2013.
-
Who acquired Incline Therapeutics?
Incline Therapeutics was acquired by The Medicines Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process